These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34818363)

  • 21. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.
    Mizoguchi K; Ikarashi Y
    Front Pharmacol; 2017; 8():149. PubMed ID: 28377723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective Analysis of Consecutive Patients.
    Matsui K; Sasai-Sakuma T; Ishigooka J; Nishimura K; Inoue Y
    J Clin Sleep Med; 2019 Aug; 15(8):1173-1178. PubMed ID: 31482840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.
    Matsumoto K; Zhao Q; Niu Y; Fujiwara H; Tanaka K; Sasaki-Hamada S; Oka J
    J Pharmacol Sci; 2013; 122(4):257-69. PubMed ID: 23883485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the benzodiazepine system in the anxiolytic-like effect of Yokukansan (Yi-gan san).
    Kamei J; Miyata S; Ohsawa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1431-7. PubMed ID: 19647028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Japanese Herbal Medicine Yokukansan Exerted Antioxidant and Analgesic Effects in an Experimental Rat Model of Hunner-Type Interstitial Cystitis.
    Inoue T; Tsukada M; Tsunokawa Y; Maeda Y; Fukuoka S; Fukagai T; Ogawa Y; Sunagawa M
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744072
    [No Abstract]   [Full Text] [Related]  

  • 27. Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats.
    Mizoguchi K; Shoji H; Tanaka Y; Tabira T
    Neuroscience; 2011 Mar; 177():127-37. PubMed ID: 21195139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder.
    Wake R; Miyaoka T; Furuya M; Hashioka S; Horiguchi J
    CNS Neurol Disord Drug Targets; 2016; 15(5):551-63. PubMed ID: 27071791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Kampo Medicine Yokukansan Decreases MicroRNA-18 Expression and Recovers Glucocorticoid Receptors Protein Expression in the Hypothalamus of Stressed Mice.
    Shimizu S; Tanaka T; Takeda T; Tohyama M; Miyata S
    Biomed Res Int; 2015; 2015():797280. PubMed ID: 26106615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines.
    Takeda T; Yamaguchi T; Yaegashi N
    Int J Clin Oncol; 2012 Apr; 17(2):143-9. PubMed ID: 21706124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats.
    Kanada Y; Katayama A; Ikemoto H; Takahashi K; Tsukada M; Nakamura A; Ishino S; Hisamitsu T; Sunagawa M
    Neuropsychiatr Dis Treat; 2018; 14():937-944. PubMed ID: 29670354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.
    Hatano T; Hattori N; Kawanabe T; Terayama Y; Suzuki N; Iwasaki Y; Fujioka T;
    J Neural Transm (Vienna); 2014; 121(3):275-81. PubMed ID: 24169925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yokukansan (Kampo medicinal formula) prevents the development of morphine tolerance by inhibiting the secretion of orexin A.
    Katayama A; Kanada Y; Tsukada M; Akanuma Y; Takemura H; Ono T; Suga H; Mera H; Hisamitsu T; Sunagawa M
    Integr Med Res; 2018 Jun; 7(2):141-148. PubMed ID: 29989049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyses of the possible anti-tumor effect of yokukansan.
    Han C; Kawata M; Hamada Y; Kondo T; Wada J; Asano K; Makabe H; Igarashi K; Kuzumaki N; Narita M; Kobayashi H; Narita M
    J Nat Med; 2019 Jun; 73(3):468-479. PubMed ID: 30739283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparison of dexmedetomidine and midazolam premedication on postoperative anxiety in children for hernia repair surgery: A randomized controlled trial.
    Du Z; Zhang XY; Qu SQ; Song ZB; Wei SW; Xiang Z; Guo QL
    Paediatr Anaesth; 2019 Aug; 29(8):843-849. PubMed ID: 31125470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of pectoral nerve block on postoperative pain and quality of recovery in patients undergoing breast cancer surgery: A randomised controlled trial.
    Kamiya Y; Hasegawa M; Yoshida T; Takamatsu M; Koyama Y
    Eur J Anaesthesiol; 2018 Mar; 35(3):215-223. PubMed ID: 29227351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-allergic mechanisms of Japanese herbal medicine, yokukansan on mast cells.
    Yamamura K; Kato S; Kato TA; Mizoguchi Y; Monji A; Kanba S; Furue M; Takeuchi S
    J Dermatol; 2014 Sep; 41(9):808-14. PubMed ID: 25156212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic Efficacy of a Combination of Fentanyl and a Japanese Herbal Medicine "
    Akanuma Y; Kato M; Takayama Y; Ikemoto H; Adachi N; Ohashi Y; Yogi W; Okumo T; Tsukada M; Sunagawa M
    Medicines (Basel); 2020 Dec; 7(12):. PubMed ID: 33348580
    [No Abstract]   [Full Text] [Related]  

  • 39. Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.
    Katahira H; Sunagawa M; Watanabe D; Kanada Y; Katayama A; Yamauchi R; Takashima M; Ishikawa S; Hisamitsu T
    Neuropsychiatr Dis Treat; 2017; 13():863-872. PubMed ID: 28360524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
    Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
    J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.